Free heme and the polymerization of sickle cell hemoglobin.
In search of novel control parameters for the polymerization of sickle cell hemoglobin (HbS), the primary pathogenic event of sickle cell anemia, we explore the role of free heme, which may be excessively released in sickle erythrocytes. We show that the concentration of free heme in HbS solutions typically used in the laboratory is 0.02-0.04 mole heme/mole HbS. We show that dialysis of small molecules out of HbS solutions arrests HbS polymerization. The addition of 100-260 μM of free heme to dialyzed HbS solutions leads to rates of nucleation and polymer fiber growth faster by two orders of magnitude than before dialysis. Toward an understanding of the mechanism of nucleation enhancement by heme, we show that free heme at a concentration of 66 μM increases by two orders of magnitude the volume of the metastable clusters of dense HbS liquid, the locations where HbS polymer nuclei form. These results suggest that spikes of the free heme concentration in the erythrocytes of sickle cell anemia patients may be a significant factor in the complexity of the clinical manifestations of sickle cell anemia. The prevention of free heme accumulation in the erythrocyte cytosol may be a novel avenue to sickle cell therapy.
Uzunova
Veselina V
VV
Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, USA.
Pan
Weichun
W
Galkin
Oleg
O
Vekilov
Peter G
PG
D004912:Erythrocytes / Q000378:metabolism; D006418:Heme / Q000378:metabolism*; D006451:Hemoglobin, Sickle / Q000737:chemistry* / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D055503:Protein Multimerization; D020836:Protein Structure, Quaternary; D012996:Solutions; D013696:Temperature
D006451:Hemoglobin, Sickle; D012996:Solutions; D006418:Heme